A carregar...

Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration

Angiogenesis is a common factor in the pathogenesis of cancer and in exudative age-related macular degeneration (AMD). Therefore, angiogenesis inhibition has been developed as a therapeutic strategy. We report 2 cases of recurrent exudative AMD in which oral sorafenib, a tyrosine kinase inhibitor ap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Diago, Teresa, Pulido, Jose S., Molina, Julian R., Collet, Lucienne C., Link, Thomas P., Ryan, Edwin H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2763274/
https://ncbi.nlm.nih.gov/pubmed/18241635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0420.2007.01014.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!